Kamada (XTAE:KMDA) Days Inventory : 336.23 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Kamada Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Kamada's Average Total Inventories for the three months ended in Dec. 2023 was ₪301.6 Mil. Kamada's Cost of Goods Sold for the three months ended in Dec. 2023 was ₪81.8 Mil. Hence, Kamada's Days Inventory for the three months ended in Dec. 2023 was 336.23.

The historical rank and industry rank for Kamada's Days Inventory or its related term are showing as below:

XTAE:KMDA' s Days Inventory Range Over the Past 10 Years
Min: 125.2 Med: 176.03 Max: 337.61
Current: 331.14

During the past 13 years, Kamada's highest Days Inventory was 337.61. The lowest was 125.20. And the median was 176.03.

XTAE:KMDA's Days Inventory is ranked worse than
86.95% of 973 companies
in the Drug Manufacturers industry
Industry Median: 157.54 vs XTAE:KMDA: 331.14

Kamada's Days Inventory increased from Dec. 2022 (220.26) to Dec. 2023 (336.23). It might indicate that Kamada's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Kamada's Inventory Turnover for the three months ended in Dec. 2023 was 0.27.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Kamada's Inventory-to-Revenue for the three months ended in Dec. 2023 was 2.23.

Kamada Days Inventory Historical Data

The historical data trend for Kamada's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kamada Days Inventory Chart

Kamada Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

171.75

183.61

285.95

318.79

337.61

Kamada Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															220.26	368.15	317.28	303.82	336.23

Competitive Comparison of Kamada's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Kamada's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kamada's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kamada's Days Inventory distribution charts can be found below:

* The bar in red indicates where Kamada's Days Inventory falls into.

Kamada Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Kamada's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (269.548	+	328.879)	/	2 )	/	323.49	*	365
=	299.2135					/	323.49	*	365
=	337.61

Kamada's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (274.298	+	328.879)	/	2 )	/	81.849	*	365 / 4
=	301.5885					/	81.849	*	365 / 4
=	336.23

Kamada (XTAE:KMDA) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Kamada's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	81.849	/	301.5885
	=	0.27

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Kamada's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	301.5885	/	135.419
	=	2.23

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Kamada Days Inventory Related Terms

Thank you for viewing the detailed overview of Kamada's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Kamada (XTAE:KMDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (XTAE:KMDA) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

KMDA:USA

Address

2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402

Website

https://www.kamada.com

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.